In PDAC, CD8+ T-cells often display elevated levels of PD-1 expression, which correlates with diminished activation and cytotoxic activity, while tumor cells express PD-L1, which further inhibits CD8+ T-cell activation [34]. The gene discussed is CD8A; the disease is neoplasm.